Literature DB >> 8803634

The venous wall and valvular function in chronic venous insufficiency.

O Thulesius1.   

Abstract

The present paper is an overview taking into account the four most important etiological factors which can be involved in the development of chronic venous insufficiency (CVI): (1) weakness of the vascular wall including connective tissue and smooth muscle, (2) dysfunction and damage of the venous endothelium, (3) damage of the venous valves and (4) disturbancies of the microcirculation. The first three can be implicated in the development of reflux and venous hypertension and it is difficult to pin-point one single factor as being the most important. Disturbancies of the microcirculation eventually lead to the typical complications of CVI. With better understanding of the disease process it is possible to attack the causative factors leading to CVI and prevent and heal complications.

Entities:  

Mesh:

Year:  1996        PMID: 8803634

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  4 in total

Review 1.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

2.  Expression of constitutive nitric oxide synthase isoforms in varicose vein wall; preliminary results.

Authors:  Zora Haviarová; Andrea Janegová; Pavel Janega; Stefan Durdík; Peter Kováč; Viera Stvrtinová; Peter Mráz
Journal:  Int J Vasc Med       Date:  2011-05-29

3.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29

4.  In vivo and in vitro assessment of human saphenous vein wall changes.

Authors:  Akram M Asbeutah; Sami K Asfar; Hussain Safar; Mabayoje A Oriowo; Ihab Elhagrassi; Mona A Abu-Assi; James D Cameron; Barry P McGrath
Journal:  Open Cardiovasc Med J       Date:  2007-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.